These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21840752)

  • 21. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
    Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
    Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
    Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
    Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance.
    Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J
    Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mediators of metastasis in head and neck squamous cell carcinoma.
    Howell GM; Grandis JR
    Head Neck; 2005 Aug; 27(8):710-7. PubMed ID: 15952195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
    Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
    Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
    J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck].
    De Stefani A; Magnano M; Bussi M; Cravero L; Lerda W; Usai A; Cavalot A; Ragona R; Gabriele P; Valente G; Cortesina G
    Acta Otorhinolaryngol Ital; 1997 Jun; 17(3):219-24. PubMed ID: 9489148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas.
    Lavaee F; Zare S; Mojtahedi Z; Malekzadeh M; Khademi B; Ghaderi A
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):901-904. PubMed ID: 29693336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the epithelial dysplasia grading and Ki67 proliferation index in the adjacent non-malignant mucosa on recurrence and survival in head and neck squamous cell carcinoma.
    Pereira CS; Oliveira MV; Fraga CA; Barros LO; Domingos PL; Roy A; De-Paula AM; Guimarães AL
    Pathol Res Pract; 2012 Nov; 208(11):651-6. PubMed ID: 22995634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparanase expression in head and neck squamous cell carcinomas is associated with reduced proliferation and improved survival.
    Mogler C; Herold-Mende C; Dyckhoff G; Jenetzky E; Beckhove P; Helmke BM
    Histopathology; 2011 May; 58(6):944-52. PubMed ID: 21585429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
    Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
    Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
    Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
    Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients.
    Hoffmann M; Görögh T; Gottschlich S; Lohrey C; Rittgen W; Ambrosch P; Schwarz E; Kahn T
    Cancer Lett; 2005 Feb; 218(2):199-206. PubMed ID: 15670897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
    Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
    Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
    Dietl B; Marienhagen J; Schäfer C; Kölbl O
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
    Lango MN; Andrews GA; Ahmad S; Feigenberg S; Tuluc M; Gaughan J; Ridge JA
    Head Neck; 2009 Mar; 31(3):328-37. PubMed ID: 18853450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.